1 Market Overview

1.1 Product Overview and Scope of Viral Vector and Plasmid DNA

1.2 Classification of Viral Vector and Plasmid DNA by Type

1.2.1 Overview: Global Viral Vector and Plasmid DNA Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Type in 2020

1.2.3 Plasmid DNA

1.2.4 Viral Vector

1.3 Global Viral Vector and Plasmid DNA Market by Application

1.3.1 Overview: Global Viral Vector and Plasmid DNA Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Cancer

1.3.3 Virus Infection

1.3.4 Hereditary Disease

1.4 Global Viral Vector and Plasmid DNA Market Size & Forecast

1.5 Global Viral Vector and Plasmid DNA Market Size and Forecast by Region

1.5.1 Global Viral Vector and Plasmid DNA Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Viral Vector and Plasmid DNA Market Size by Region, (2016-2021)

1.5.3 North America Viral Vector and Plasmid DNA Market Size and Prospect (2016-2026)

1.5.4 Europe Viral Vector and Plasmid DNA Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Viral Vector and Plasmid DNA Market Size and Prospect (2016-2026)

1.5.6 South America Viral Vector and Plasmid DNA Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Viral Vector and Plasmid DNA Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Viral Vector and Plasmid DNA Market Drivers

1.6.2 Viral Vector and Plasmid DNA Market Restraints

1.6.3 Viral Vector and Plasmid DNA Trends Analysis

2 Company Profiles

2.1 Brammer Bio

2.1.1 Brammer Bio Details

2.1.2 Brammer Bio Major Business

2.1.3 Brammer Bio Viral Vector and Plasmid DNA Product and Solutions

2.1.4 Brammer Bio Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Brammer Bio Recent Developments and Future Plans

2.2 Oxford BioMedica

2.2.1 Oxford BioMedica Details

2.2.2 Oxford BioMedica Major Business

2.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Product and Solutions

2.2.4 Oxford BioMedica Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Oxford BioMedica Recent Developments and Future Plans

2.3 Cobra Biologics

2.3.1 Cobra Biologics Details

2.3.2 Cobra Biologics Major Business

2.3.3 Cobra Biologics Viral Vector and Plasmid DNA Product and Solutions

2.3.4 Cobra Biologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Cobra Biologics Recent Developments and Future Plans

2.4 FinVector

2.4.1 FinVector Details

2.4.2 FinVector Major Business

2.4.3 FinVector Viral Vector and Plasmid DNA Product and Solutions

2.4.4 FinVector Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 FinVector Recent Developments and Future Plans

2.5 Lonza

2.5.1 Lonza Details

2.5.2 Lonza Major Business

2.5.3 Lonza Viral Vector and Plasmid DNA Product and Solutions

2.5.4 Lonza Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Lonza Recent Developments and Future Plans

2.6 BioReliance

2.6.1 BioReliance Details

2.6.2 BioReliance Major Business

2.6.3 BioReliance Viral Vector and Plasmid DNA Product and Solutions

2.6.4 BioReliance Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 BioReliance Recent Developments and Future Plans

2.7 MolMed

2.7.1 MolMed Details

2.7.2 MolMed Major Business

2.7.3 MolMed Viral Vector and Plasmid DNA Product and Solutions

2.7.4 MolMed Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 MolMed Recent Developments and Future Plans

2.8 FUJIFILM Diosynth Biotechnologies

2.8.1 FUJIFILM Diosynth Biotechnologies Details

2.8.2 FUJIFILM Diosynth Biotechnologies Major Business

2.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product and Solutions

2.8.4 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

2.9 UniQure

2.9.1 UniQure Details

2.9.2 UniQure Major Business

2.9.3 UniQure Viral Vector and Plasmid DNA Product and Solutions

2.9.4 UniQure Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 UniQure Recent Developments and Future Plans

2.10 Aldevron

2.10.1 Aldevron Details

2.10.2 Aldevron Major Business

2.10.3 Aldevron Viral Vector and Plasmid DNA Product and Solutions

2.10.4 Aldevron Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Aldevron Recent Developments and Future Plans

2.11 Richter-Helm

2.11.1 Richter-Helm Details

2.11.2 Richter-Helm Major Business

2.11.3 Richter-Helm Viral Vector and Plasmid DNA Product and Solutions

2.11.4 Richter-Helm Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Richter-Helm Recent Developments and Future Plans

2.12 Eurogentec

2.12.1 Eurogentec Details

2.12.2 Eurogentec Major Business

2.12.3 Eurogentec Viral Vector and Plasmid DNA Product and Solutions

2.12.4 Eurogentec Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Eurogentec Recent Developments and Future Plans

2.13 OBiO Technology

2.13.1 OBiO Technology Details

2.13.2 OBiO Technology Major Business

2.13.3 OBiO Technology Viral Vector and Plasmid DNA Product and Solutions

2.13.4 OBiO Technology Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 OBiO Technology Recent Developments and Future Plans

2.14 Yposkesi

2.14.1 Yposkesi Details

2.14.2 Yposkesi Major Business

2.14.3 Yposkesi Viral Vector and Plasmid DNA Product and Solutions

2.14.4 Yposkesi Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Yposkesi Recent Developments and Future Plans

2.15 Cell and Gene Therapy Catapult

2.15.1 Cell and Gene Therapy Catapult Details

2.15.2 Cell and Gene Therapy Catapult Major Business

2.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product and Solutions

2.15.4 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans

2.16 MassBiologics

2.16.1 MassBiologics Details

2.16.2 MassBiologics Major Business

2.16.3 MassBiologics Viral Vector and Plasmid DNA Product and Solutions

2.16.4 MassBiologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 MassBiologics Recent Developments and Future Plans

2.17 Biovian

2.17.1 Biovian Details

2.17.2 Biovian Major Business

2.17.3 Biovian Viral Vector and Plasmid DNA Product and Solutions

2.17.4 Biovian Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Biovian Recent Developments and Future Plans

2.18 VGXI

2.18.1 VGXI Details

2.18.2 VGXI Major Business

2.18.3 VGXI Viral Vector and Plasmid DNA Product and Solutions

2.18.4 VGXI Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 VGXI Recent Developments and Future Plans

2.19 Gene Synthesis

2.19.1 Gene Synthesis Details

2.19.2 Gene Synthesis Major Business

2.19.3 Gene Synthesis Viral Vector and Plasmid DNA Product and Solutions

2.19.4 Gene Synthesis Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Gene Synthesis Recent Developments and Future Plans

2.20 PlasmidFactory

2.20.1 PlasmidFactory Details

2.20.2 PlasmidFactory Major Business

2.20.3 PlasmidFactory Viral Vector and Plasmid DNA Product and Solutions

2.20.4 PlasmidFactory Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 PlasmidFactory Recent Developments and Future Plans

2.21 Jikai Gene

2.21.1 Jikai Gene Details

2.21.2 Jikai Gene Major Business

2.21.3 Jikai Gene Viral Vector and Plasmid DNA Product and Solutions

2.21.4 Jikai Gene Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Jikai Gene Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Viral Vector and Plasmid DNA Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Viral Vector and Plasmid DNA Players Market Share

3.2.2 Top 10 Viral Vector and Plasmid DNA Players Market Share

3.2.3 Market Competition Trend

3.3 Viral Vector and Plasmid DNA Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Viral Vector and Plasmid DNA Revenue and Market Share by Type (2016-2021)

4.2 Global Viral Vector and Plasmid DNA Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2016-2021)

5.2 Viral Vector and Plasmid DNA Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Viral Vector and Plasmid DNA Revenue by Type (2016-2026)

6.2 North America Viral Vector and Plasmid DNA Revenue by Application (2016-2026)

6.3 North America Viral Vector and Plasmid DNA Market Size by Country

6.3.1 North America Viral Vector and Plasmid DNA Revenue by Country (2016-2026)

6.3.2 United States Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

6.3.3 Canada Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

6.3.4 Mexico Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Viral Vector and Plasmid DNA Revenue by Type (2016-2026)

7.2 Europe Viral Vector and Plasmid DNA Revenue by Application (2016-2026)

7.3 Europe Viral Vector and Plasmid DNA Market Size by Country

7.3.1 Europe Viral Vector and Plasmid DNA Revenue by Country (2016-2026)

7.3.2 Germany Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

7.3.3 France Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

7.3.5 Russia Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

7.3.6 Italy Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Type (2016-2026)

8.2 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Application (2016-2026)

8.3 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region

8.3.1 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Region (2016-2026)

8.3.2 China Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

8.3.3 Japan Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

8.3.4 South Korea Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

8.3.5 India Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

8.3.7 Australia Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Viral Vector and Plasmid DNA Revenue by Type (2016-2026)

9.2 South America Viral Vector and Plasmid DNA Revenue by Application (2016-2026)

9.3 South America Viral Vector and Plasmid DNA Market Size by Country

9.3.1 South America Viral Vector and Plasmid DNA Revenue by Country (2016-2026)

9.3.2 Brazil Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

9.3.3 Argentina Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Viral Vector and Plasmid DNA Revenue by Type (2016-2026)

10.2 Middle East & Africa Viral Vector and Plasmid DNA Revenue by Application (2016-2026)

10.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country

10.3.1 Middle East & Africa Viral Vector and Plasmid DNA Revenue by Country (2016-2026)

10.3.2 Turkey Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

10.3.4 UAE Viral Vector and Plasmid DNA Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Viral Vector and Plasmid DNA Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Viral Vector and Plasmid DNA Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Viral Vector and Plasmid DNA Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Viral Vector and Plasmid DNA Revenue (USD Million) by Region (2016-2021)

Table 5. Global Viral Vector and Plasmid DNA Revenue Market Share by Region (2021-2026)

Table 6. Brammer Bio Corporate Information, Head Office, and Major Competitors

Table 7. Brammer Bio Major Business

Table 8. Brammer Bio Viral Vector and Plasmid DNA Product and Solutions

Table 9. Brammer Bio Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Oxford BioMedica Corporate Information, Head Office, and Major Competitors

Table 11. Oxford BioMedica Major Business

Table 12. Oxford BioMedica Viral Vector and Plasmid DNA Product and Solutions

Table 13. Oxford BioMedica Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Cobra Biologics Corporate Information, Head Office, and Major Competitors

Table 15. Cobra Biologics Major Business

Table 16. Cobra Biologics Viral Vector and Plasmid DNA Product and Solutions

Table 17. Cobra Biologics Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. FinVector Corporate Information, Head Office, and Major Competitors

Table 19. FinVector Major Business

Table 20. FinVector Viral Vector and Plasmid DNA Product and Solutions

Table 21. FinVector Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Lonza Corporate Information, Head Office, and Major Competitors

Table 23. Lonza Major Business

Table 24. Lonza Viral Vector and Plasmid DNA Product and Solutions

Table 25. Lonza Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. BioReliance Corporate Information, Head Office, and Major Competitors

Table 27. BioReliance Major Business

Table 28. BioReliance Viral Vector and Plasmid DNA Product and Solutions

Table 29. BioReliance Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. MolMed Corporate Information, Head Office, and Major Competitors

Table 31. MolMed Major Business

Table 32. MolMed Viral Vector and Plasmid DNA Product and Solutions

Table 33. MolMed Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. FUJIFILM Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors

Table 35. FUJIFILM Diosynth Biotechnologies Major Business

Table 36. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product and Solutions

Table 37. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. UniQure Corporate Information, Head Office, and Major Competitors

Table 39. UniQure Major Business

Table 40. UniQure Viral Vector and Plasmid DNA Product and Solutions

Table 41. UniQure Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Aldevron Corporate Information, Head Office, and Major Competitors

Table 43. Aldevron Major Business

Table 44. Aldevron Viral Vector and Plasmid DNA Product and Solutions

Table 45. Aldevron Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Richter-Helm Corporate Information, Head Office, and Major Competitors

Table 47. Richter-Helm Major Business

Table 48. Richter-Helm Viral Vector and Plasmid DNA Product and Solutions

Table 49. Richter-Helm Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Eurogentec Corporate Information, Head Office, and Major Competitors

Table 51. Eurogentec Major Business

Table 52. Eurogentec Viral Vector and Plasmid DNA Product and Solutions

Table 53. Eurogentec Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. OBiO Technology Corporate Information, Head Office, and Major Competitors

Table 55. OBiO Technology Major Business

Table 56. OBiO Technology Viral Vector and Plasmid DNA Product and Solutions

Table 57. OBiO Technology Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Yposkesi Corporate Information, Head Office, and Major Competitors

Table 59. Yposkesi Major Business

Table 60. Yposkesi Viral Vector and Plasmid DNA Product and Solutions

Table 61. Yposkesi Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Cell and Gene Therapy Catapult Corporate Information, Head Office, and Major Competitors

Table 63. Cell and Gene Therapy Catapult Major Business

Table 64. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product and Solutions

Table 65. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. MassBiologics Corporate Information, Head Office, and Major Competitors

Table 67. MassBiologics Major Business

Table 68. MassBiologics Viral Vector and Plasmid DNA Product and Solutions

Table 69. MassBiologics Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Biovian Corporate Information, Head Office, and Major Competitors

Table 71. Biovian Major Business

Table 72. Biovian Viral Vector and Plasmid DNA Product and Solutions

Table 73. Biovian Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. VGXI Corporate Information, Head Office, and Major Competitors

Table 75. VGXI Major Business

Table 76. VGXI Viral Vector and Plasmid DNA Product and Solutions

Table 77. VGXI Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Gene Synthesis Corporate Information, Head Office, and Major Competitors

Table 79. Gene Synthesis Major Business

Table 80. Gene Synthesis Viral Vector and Plasmid DNA Product and Solutions

Table 81. Gene Synthesis Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. PlasmidFactory Corporate Information, Head Office, and Major Competitors

Table 83. PlasmidFactory Major Business

Table 84. PlasmidFactory Viral Vector and Plasmid DNA Product and Solutions

Table 85. PlasmidFactory Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Jikai Gene Corporate Information, Head Office, and Major Competitors

Table 87. Jikai Gene Major Business

Table 88. Jikai Gene Viral Vector and Plasmid DNA Product and Solutions

Table 89. Jikai Gene Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Global Viral Vector and Plasmid DNA Revenue (USD Million) by Players (2019-2021)

Table 91. Global Viral Vector and Plasmid DNA Revenue Share by Players (2019-2021)

Table 92. Breakdown of Viral Vector and Plasmid DNA by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Viral Vector and Plasmid DNA Players Head Office, Products and Services Provided

Table 94. Viral Vector and Plasmid DNA Mergers & Acquisitions in the Past Five Years

Table 95. Viral Vector and Plasmid DNA New Entrants and Expansion Plans

Table 96. Global Viral Vector and Plasmid DNA Revenue (USD Million) by Type (2016-2021)

Table 97. Global Viral Vector and Plasmid DNA Revenue Share by Type (2016-2021)

Table 98. Global Viral Vector and Plasmid DNA Revenue Forecast by Type (2021-2026)

Table 99. Global Viral Vector and Plasmid DNA Revenue by Application (2016-2021)

Table 100. Global Viral Vector and Plasmid DNA Revenue Forecast by Application (2021-2026)

Table 101. North America Viral Vector and Plasmid DNA Revenue by Type (2016-2021) & (USD Million)

Table 102. North America Viral Vector and Plasmid DNA Revenue by Type (2021-2026) & (USD Million)

Table 103. North America Viral Vector and Plasmid DNA Revenue by Application (2016-2021) & (USD Million)

Table 104. North America Viral Vector and Plasmid DNA Revenue by Application (2021-2026) & (USD Million)

Table 105. North America Viral Vector and Plasmid DNA Revenue by Country (2016-2021) & (USD Million)

Table 106. North America Viral Vector and Plasmid DNA Revenue by Country (2021-2026) & (USD Million)

Table 107. Europe Viral Vector and Plasmid DNA Revenue by Type (2016-2021) & (USD Million)

Table 108. Europe Viral Vector and Plasmid DNA Revenue by Type (2021-2026) & (USD Million)

Table 109. Europe Viral Vector and Plasmid DNA Revenue by Application (2016-2021) & (USD Million)

Table 110. Europe Viral Vector and Plasmid DNA Revenue by Application (2021-2026) & (USD Million)

Table 111. Europe Viral Vector and Plasmid DNA Revenue by Country (2016-2021) & (USD Million)

Table 112. Europe Viral Vector and Plasmid DNA Revenue by Country (2021-2026) & (USD Million)

Table 113. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Type (2016-2021) & (USD Million)

Table 114. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Type (2021-2026) & (USD Million)

Table 115. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Application (2016-2021) & (USD Million)

Table 116. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Application (2021-2026) & (USD Million)

Table 117. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Region (2016-2021) & (USD Million)

Table 118. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Region (2021-2026) & (USD Million)

Table 119. South America Viral Vector and Plasmid DNA Revenue by Type (2016-2021) & (USD Million)

Table 120. South America Viral Vector and Plasmid DNA Revenue by Type (2021-2026) & (USD Million)

Table 121. South America Viral Vector and Plasmid DNA Revenue by Application (2016-2021) & (USD Million)

Table 122. South America Viral Vector and Plasmid DNA Revenue by Application (2021-2026) & (USD Million)

Table 123. South America Viral Vector and Plasmid DNA Revenue by Country (2016-2021) & (USD Million)

Table 124. South America Viral Vector and Plasmid DNA Revenue by Country (2021-2026) & (USD Million)

Table 125. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Type (2016-2021) & (USD Million)

Table 126. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Type (2021-2026) & (USD Million)

Table 127. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Application (2016-2021) & (USD Million)

Table 128. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Application (2021-2026) & (USD Million)

Table 129. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Country (2016-2021) & (USD Million)

Table 130. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Viral Vector and Plasmid DNA Picture

Figure 2. Global Viral Vector and Plasmid DNA Revenue Market Share by Type in 2020

Figure 3. Plasmid DNA

Figure 4. Viral Vector

Figure 5. Viral Vector and Plasmid DNA Revenue Market Share by Application in 2020

Figure 6. Cancer Picture

Figure 7. Virus Infection Picture

Figure 8. Hereditary Disease Picture

Figure 9. Global Viral Vector and Plasmid DNA Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Viral Vector and Plasmid DNA Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Viral Vector and Plasmid DNA Revenue Market Share by Region (2016-2026)

Figure 12. Global Viral Vector and Plasmid DNA Revenue Market Share by Region in 2020

Figure 13. North America Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Viral Vector and Plasmid DNA Market Drivers

Figure 19. Viral Vector and Plasmid DNA Market Restraints

Figure 20. Viral Vector and Plasmid DNA Market Trends

Figure 21. Brammer Bio Recent Developments and Future Plans

Figure 22. Oxford BioMedica Recent Developments and Future Plans

Figure 23. Cobra Biologics Recent Developments and Future Plans

Figure 24. FinVector Recent Developments and Future Plans

Figure 25. Lonza Recent Developments and Future Plans

Figure 26. BioReliance Recent Developments and Future Plans

Figure 27. MolMed Recent Developments and Future Plans

Figure 28. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

Figure 29. UniQure Recent Developments and Future Plans

Figure 30. Aldevron Recent Developments and Future Plans

Figure 31. Richter-Helm Recent Developments and Future Plans

Figure 32. Eurogentec Recent Developments and Future Plans

Figure 33. OBiO Technology Recent Developments and Future Plans

Figure 34. Yposkesi Recent Developments and Future Plans

Figure 35. Cell and Gene Therapy Catapult Recent Developments and Future Plans

Figure 36. MassBiologics Recent Developments and Future Plans

Figure 37. Biovian Recent Developments and Future Plans

Figure 38. VGXI Recent Developments and Future Plans

Figure 39. Gene Synthesis Recent Developments and Future Plans

Figure 40. PlasmidFactory Recent Developments and Future Plans

Figure 41. Jikai Gene Recent Developments and Future Plans

Figure 42. Global Viral Vector and Plasmid DNA Revenue Share by Players in 2020

Figure 43. Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players Viral Vector and Plasmid DNA Revenue Market Share in 2020

Figure 45. Global Top 10 Players Viral Vector and Plasmid DNA Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global Viral Vector and Plasmid DNA Revenue Share by Type in 2020

Figure 48. Global Viral Vector and Plasmid DNA Market Share Forecast by Type (2021-2026)

Figure 49. Global Viral Vector and Plasmid DNA Revenue Share by Application in 2020

Figure 50. Global Viral Vector and Plasmid DNA Market Share Forecast by Application (2021-2026)

Figure 51. North America Viral Vector and Plasmid DNA Sales Market Share by Type (2016-2026)

Figure 52. North America Viral Vector and Plasmid DNA Sales Market Share by Application (2016-2026)

Figure 53. North America Viral Vector and Plasmid DNA Revenue Market Share by Country (2016-2026)

Figure 54. United States Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe Viral Vector and Plasmid DNA Sales Market Share by Type (2016-2026)

Figure 58. Europe Viral Vector and Plasmid DNA Sales Market Share by Application (2016-2026)

Figure 59. Europe Viral Vector and Plasmid DNA Revenue Market Share by Country (2016-2026)

Figure 60. Germany Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific Viral Vector and Plasmid DNA Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific Viral Vector and Plasmid DNA Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific Viral Vector and Plasmid DNA Revenue Market Share by Region (2016-2026)

Figure 68. China Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America Viral Vector and Plasmid DNA Sales Market Share by Type (2016-2026)

Figure 75. South America Viral Vector and Plasmid DNA Sales Market Share by Application (2016-2026)

Figure 76. South America Viral Vector and Plasmid DNA Revenue Market Share by Country (2016-2026)

Figure 77. Brazil Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa Viral Vector and Plasmid DNA Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa Viral Vector and Plasmid DNA Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa Viral Vector and Plasmid DNA Revenue Market Share by Country (2016-2026)

Figure 82. Turkey Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE Viral Vector and Plasmid DNA Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source